1. Introduction {#sec1}
===============

Epilepsy is a chronic episodic noncommunicable disorder of the brain due to abnormal excessive or synchronous neuronal activity. This disorder affects about 50 million people worldwide, and idiopathic epilepsy represents the majority of all epileptic seizure disorders \[[@B1]--[@B3]\]. There is increasing evidence that demonstrates genetic factors play a crucial role in the development of idiopathic epilepsy; these findings are mostly based on epidemiological studies, including those of familial aggregation, monozygotic twins, and families with a history of epilepsy \[[@B4]--[@B6]\].

Orthodenticle homeobox 1 (*OTX1*) is one of the homeobox genes that belongs to the *OTX* family (*OTX1*, *OTX2*, *OTX3*, and *CRX*) \[[@B7], [@B8]\]. The *OTX1* gene encodes transcription factors that have high affinity for TAATCC/T elements on target genes \[[@B9]\] involved in brain regionalization, corticogenesis, and organ development sense during embryogenesis \[[@B10]\]. *OTX1* expression gradually declines but remains at detectable levels in the deep cortical layers of mature rats \[[@B11]\]. The *OTX1* mutant mice showed a circle-running behavior, which exhibited spontaneous epileptic seizures exemplified by upper extremity clonus, rearing, falling, and convulsions starting at the fourth postnatal week \[[@B12]\]. In these mice, neuronal populations in the cortex displayed abnormal electrical activities during convulsive seizures \[[@B13]\].

The main objective of this study was to assess the polymorphisms of the *OTX1* coding sequences in a cohort of patients from China based on the hypothesis that these polymorphisms are potentially predictive of epilepsy.

2. Patients and Methods {#sec2}
=======================

2.1. Patients {#sec2.1}
-------------

A total of 147 patients with idiopathic epilepsy and 121 healthy individuals were consecutively recruited in our hospital from July 2015 to July 2018. All patients fulfilled the requirements of the International League Against Epilepsy classification for idiopathic epilepsy \[[@B14]\]. Patients with other comorbid conditions that might have been associated with brain structure alterations, such as intracranial tumors, cerebrovascular disease, metabolic encephalopathy, dementia, language disabilities, and activity disorders, were excluded. None of the control participants had a history of a central nervous system disorder or any other medical disorders.

2.2. DNA Extraction and Genotyping {#sec2.2}
----------------------------------

We purified genomic DNA from EDTA-anticoagulated blood samples using the QIAamp DNA Mini Kit (Qiagen, lot no. 51304). After DNA extraction, the concentration and purity of DNA were detected using the NenoDrop2000 (Thermo). DNA with a 260/280 ratio value of approximately 1.8 and a concentration of greater than 50 ng/ml were accepted. The primer sequences were designed using Primer 5 software. If the designed primers could not amplify the first time, we tested other primers and chose the best primers for amplification. The *OTX1* coding sequence was divided into 3 parts ([Figure 1(a)](#fig1){ref-type="fig"}) and amplified with PCR using PrimeSTAR® Max DNA Polymerase (Takara, Lot no. R045Q). The PCR reaction tube (50 *μ*l) included 25 *μ*l of the PrimeSTAR Max Premix, 4 *μ*l of primers (0.25 *μ*M), 2 *μ*l of a genomic DNA template (100 ng), and 19 *μ*l of nuclease-free water (Thermo, AM9932) following instructions from the PrimeSTAR® Max DNA Polymerase manual. All amplifications were performed at 98°C. The DNA was denatured for 5 min at 98°C, and then, the cycling continued at 98°C for 10s, 60°C for 15 s, 72°C for 60s (total 32 cycles), and 72°C for 10 min (holding). For the *OTX1* amplification, we also amplified *β*-actin (about 500 bp) as the positive control and used nuclease-free water as the negative control. Fortunately, *β*-actin amplification was universal in three parts of the OTX1 amplification. The PCR products were sent to Shanghai Thermo Fisher Ltd. for Sanger sequencing and analysis. The primer sequences used for PCR and sequencing are listed in [Table 1](#tab1){ref-type="table"}.

2.3. Statistical Analysis {#sec2.3}
-------------------------

Variables were described as the mean and standard deviation or proportion. Differences between participants with and without idiopathic epilepsy were analyzed using chi-square analysis. A *p* value of \<0.05 was considered statistically significant. All statistical analyses were performed using SPSS 17 software (IBM, Cary, NC). Power analyses were conducted using Power and Sample Size Calculation Software (<http://powerandsamplesize.com/Calculators/>). The *OTX1* polymorphism genotype distributions in the control group were tested for their conformity to the Hardy-Weinberg equilibrium (HWE). A *p* value of \>0.05 indicated HWE.

3. Results {#sec3}
==========

A total of 147 patients with idiopathic epilepsy met inclusion criteria and were included in this study. The mean age was 39.2 years (range 19.8--55.2 years), the female-to-male ratio was 66 : 81, and the mean duration of epilepsy was 4.1 years (range 0--32 years). One hundred and one patients presented with generalized seizures, and 46 patients presented with focal seizures. The demographic and clinical characteristics of the idiopathic epileptic patients are shown in [Table 2](#tab2){ref-type="table"}. One hundred and fifty age- and sex-matched healthy individuals from the same period were recruited to participate in the study as the control group.

After repeated PCR amplification and genotyping, one single-nucleotide polymorphism (SNP) was found in exon-5, and the gene sequence of this site was CACTCACATCACCACCCGCACCAGCT\[C/G\] AGCCCCATGGCACCCTCCTCCATGC ([Figure 1(b)](#fig1){ref-type="fig"}). After blasting this sequence in an SNP database, the SNP number was discovered to be rs17850223.

The distribution of the rs17850223 polymorphism genotypes in the control group was consistent with HWE (*p* \> 0.05), indicating that our study population came from a Mendelian population and possessed fine representativeness. As shown in [Table 3](#tab3){ref-type="table"}, further analysis showed that there were no significant differences in the genotype frequency or rs17850223 G allelic distributions between patients with idiopathic epilepsy and control individuals.

When comparing the differences between patients with generalized seizures and the controls, we found that the GG genotype frequency was significantly higher in the patients with generalized seizures compared with those of the controls (12.2% vs. 2%, *p* = 0.012), and there was also a greater distribution of the rs17850223 G allele in the patients with generalized seizures compared with that of the controls (*p* = 0.049) ([Table 4](#tab4){ref-type="table"}). However, no significant differences were found in genotype frequencies or rs17850223 G allelic distributions between the patients with focal seizures and the controls ([Table 5](#tab5){ref-type="table"}).

4. Discussion {#sec4}
=============

Epilepsy is a leading neurologic condition triggered by the disruption of abnormal electrochemical activities in the brain. Idiopathic epilepsy, with no apparent structural brain damage or neurologic abnormality, is mainly caused by genetic factors \[[@B4]--[@B6]\]. The *OTX1* gene encodes a member of the bicoid subfamily of homeodomain-containing transcription factors. The encoded protein acts as a transcription factor and might play a role in the brain and sensory organ development \[[@B15], [@B16]\]. Early animal studies indicate that *OTX1* null mice suffered from spontaneous epileptic seizures and exhibited abnormalities that primarily affected the entire dorsal telencephalic cortex with a more pronounced effect in the temporal and perirhinal areas \[[@B12], [@B17]\]. Recently, Zhang et al. found that *OTX1* expression was essential for the normal development of dendritic morphology, intrinsic electrophysiology, and synaptic dynamics of layer V pyramidal cells in the cerebral cortex \[[@B18]\]. In line with this, another study using mosaic analysis with double markers found that *OTX1* knockouts in cortical progenitors reduce the unitary output of the cortical neurons \[[@B19]\].

Previous basic studies considered that *OTX1* played a crucial role in the development and evolution of the brain, having a protective effect on epilepsy. However, the relationship between the *OTX1* gene and patients with idiopathic epilepsy has not been thoroughly investigated. According to our results, idiopathic epileptic patients with generalized seizures had a significantly greater number of rs17850223 mutations compared with controls. The frequency of the GG genotype and rs17850223 G allele was significantly higher in patients with generalized seizure compared with those of the controls. After blasting the SNP database, the homologous codon was found to be CTC, and some patients with generalized seizures had CTG mutations. However, CTC and CTG encode the same amino acid (L-leucine), which indicated a synonymous mutation.

Owing to the degeneracy of the genetic code, synonymous mutations occurring in the gene coding regions do not change the amino acid composition of the encoded proteins. However, evidence suggests that synonymous mutations could also have functional consequences \[[@B20]--[@B24]\] and could result in aberrant mRNA splicing leading to human diseases \[[@B20]\]. Studies also suggested that synonymous SNPs could affect mRNA stability and thus protein expression and enzymatic activity \[[@B21]\]. In addition, it was demonstrated that SNPs could affect protein conformations, which have functional and clinical consequences \[[@B22]\].

Our results indicated that rs17850223 could play a key role in patients with generalized seizures. However, this study had a few limitations. First, the relatively small number of patients could cause false-positive results, especially given the fact that in genetic research, the sample size is a determining factor. Second, we assessed the polymorphisms of *OTX1* coding regions but did not assess the noncoding regions, which could also play a role in idiopathic epilepsy. Furthermore, the identified association should be validated in other populations with different racial and ethnic backgrounds. As this was a preliminary study, additional studies should be performed that look at the whole gene sequence in a larger cohort of patients with different ethnicities to clarify the genetic association between *OTX1* polymorphisms and epilepsy.

In conclusion, this study compared an association between *OTX1* gene polymorphisms and idiopathic epilepsy in Han Chinese Han people. We found that rs17850223 might play a critical role in patients with generalized seizures. The results of this study provided a new understanding regarding the generation of epileptic seizures in patients with idiopathic epilepsy.
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###### 

Polymerase chain reaction (PCR) primer sequences of the *OTX1* gene.

  *OTX1*                            PCR primer sequences             Sequencing primer
  --------------------------------- -------------------------------- -------------------
  *Exon3*-cds                       P1 primer: TTCTGTAACCTGCCTTCCC   ✔
  P2 primer: CTCACACGCCCACGACTCT                                     
                                                                     
  *Exon4*-cds                       P3 primer: GCACTTTCTCCCACCTGT    ✔
  P4 primer: AGTCTGTAAGCCCACCCC                                      
                                                                     
  *Exon5*-cds                       P5 primer: CTCGGTGAGAAAGGATTG    ✔
  P6 primer: GAAGGGGGGAAATAATACAT                                    

cds: coding sequence.

###### 

Demographic and clinical characteristics of the patients with idiopathic epilepsy.

  Variables                             Patients (*n* = 147)
  ------------------------------------- ----------------------
  Male (*n*, %)                         81 (55.1)
  Age (years)                           39.2 ± 10.7
  Duration (years)                      4.1 (0--32)
  Seizure type                          
   Partial (*n*, %)                     106 (72.1)
   Generalized (*n*, %)                 41 (27.9)
  Family history of epilepsy (*n*, %)   26 (17.7)
  Age at first seizure (years)          21.2 (8.2--45.4)
  Therapy                               
   Carbamazepine (*n*, %)               50 (34)
   Oxcarbazepine (*n*, %)               38 (25.8)
   Valproic acid (*n*, %)               36 (24.5)
   Others (*n*, %)                      23 (15.6)

Data are shown as mean ± SD, median (range), or *n* (%).

###### 

The distribution of the *OTX1* rs17850223 genotypes in patients with idiopathic epilepsy and the controls.

  Variables           Patients (*n* = 147)   Controls (*n* = 150)   *p* value   *P* ~HWE~ for controls
  ------------------- ---------------------- ---------------------- ----------- ------------------------
  Genotype (*n*, %)                                                             0.135
   CC                 126 (85.7)             124 (82.7)             0.526       
   CG                 15 (10.2)              23 (15.3)              0.225       
   GG                 6 (4.1)                3 (2)                  0.332       
  Allele (*n*, %)                                                   0.781       
   C                  267 (90.8)             270 (90)                           
   G                  27 (9.2)               30 (10)                            

HWE: Hardy-Weinberg equilibrium. Data are shown as *n* (%).

###### 

The distribution of the *OTX1* rs17850223 genotypes in patients with generalized seizures and the controls.

  Variables           Generalized seizure (*n* = 41)   Controls (*n* = 150)   *p* value
  ------------------- -------------------------------- ---------------------- -----------
  Genotype (*n*, %)                                                           
   CC                 31 (75.6)                        124 (82.7)             0.367
   CG                 5 (12.2)                         23 (15.3)              0.804
   GG                 5 (12.2)                         3 (2)                  0.012^∗^
  Allele (*n*, %)                                                             0.049^∗^
   C                  67 (81.7)                        270 (90)               
   G                  15 (18.3)                        30 (10)                

Data are shown as *n* (%); ^∗^*p* \< 0.05.

###### 

The distribution of the *OTX1* rs17850223 genotypes in patients with focal seizures and the controls.

  Variables           Focal seizure (*n* = 106)   Controls (*n* = 150)   *p* value
  ------------------- --------------------------- ---------------------- -----------
  Genotype (*n*, %)                                                      
   CC                 95 (89.6)                   124 (82.7)             0.149
   CG                 10 (9.4)                    23 (15.3)              0.189
   GG                 1 (0.9)                     3 (2)                  0.644
  Allele (*n*, %)                                                        1.000
   C                  190 (90)                    270 (90)               
   G                  21 (10)                     30 (10)                

Data are shown as *n* (%).
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